LENZ
Price
$4.79
Change
+$0.06 (+1.27%)
Updated
Aug 17 closing price
Capitalization
150.5M
One day until earnings call
Intraday BUY SELL Signals
SLXN
Price
$0.40
Change
-$0.02 (-4.76%)
Updated
Aug 18, 10:54 AM (EDT)
Capitalization
558.49K
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

LENZ vs SLXN

LENZ vs SLXN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LENZ vs. SLXN commentary
Aug 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LENZ is a Hold and SLXN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2026
Stock price -- (LENZ: $4.79 vs. SLXN: $0.42)
Brand notoriety: LENZ and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LENZ: 78% vs. SLXN: 135%
Market capitalization -- LENZ: $150.5M vs. SLXN: $558.49K
LENZ [@Biotechnology] is valued at $150.5M. SLXN’s [@Biotechnology] market capitalization is $558.49K. The market cap for tickers in the [@Biotechnology] industry ranges from $130.67B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LENZ’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 1 green FA rating(s).

  • LENZ’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 1 green, 4 red.
According to our system of comparison, both LENZ and SLXN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LENZ’s TA Score shows that 4 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • LENZ’s TA Score: 4 bullish, 4 bearish.
  • SLXN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than LENZ.

Price Growth

LENZ (@Biotechnology) experienced а -10.63% price change this week, while SLXN (@Biotechnology) price change was -71.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.95%. For the same industry, the average monthly price growth was +0.37%, and the average quarterly price growth was +2944.42%.

Reported Earning Dates

LENZ is expected to report earnings on Aug 19, 2026.

SLXN is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (+0.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LENZ($151M) has a higher market cap than SLXN($558K). LENZ has higher P/E ratio than SLXN: LENZ (48.03) vs SLXN (0.00). LENZ YTD gains are higher at: -70.063 vs. SLXN (-97.802). SLXN has higher annual earnings (EBITDA): -12.91M vs. LENZ (-117.98M). LENZ has more cash in the bank: 258M vs. SLXN (2.41M). LENZ has less debt than SLXN: LENZ (673K) vs SLXN (1.99M). LENZ has higher revenues than SLXN: LENZ (21M) vs SLXN (0).
LENZSLXNLENZ / SLXN
Capitalization151M558K27,061%
EBITDA-117.98M-12.91M914%
Gain YTD-70.063-97.80272%
P/E Ratio48.030.001,165,218%
Revenue21M0-
Total Cash258M2.41M10,692%
Total Debt673K1.99M34%
TECHNICAL ANALYSIS
Technical Analysis
LENZSLXN
RSI
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
49%
Momentum
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
39%
MACD
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 5 days ago
38%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
78%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 19 days ago
55%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
61%
Aroon
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
LENZ
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SUHIX48.01N/A
N/A
DWS Health and Wellness Inst
ALVOX148.93N/A
N/A
Alger Capital Appreciation Ptfl I-2
SDGTX137.70N/A
N/A
DWS Capital Growth Institutional
JVAIX43.21N/A
N/A
JPMorgan Value Advantage L
RYBAX87.18N/A
N/A
Rydex Basic Materials H

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with LKFT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then LKFT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+1.27%
LKFT - LENZ
38%
Loosely correlated
-0.04%
MLTX - LENZ
37%
Loosely correlated
-0.73%
CELC - LENZ
36%
Loosely correlated
+0.48%
BCYC - LENZ
36%
Loosely correlated
+2.56%
KRYS - LENZ
34%
Loosely correlated
+1.04%
More